Raras
Buscar doenças, sintomas, genes...
Febre macular por rickettsiose
ORPHA:102022CID-10 · A77CID-11 · 1C31DOENÇA RARA

É um tipo de doença transmitida por carrapatos que aparece na pele, causada por bactérias do gênero Rickettsia.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

É um tipo de doença transmitida por carrapatos que aparece na pele, causada por bactérias do gênero Rickettsia.

Publicações científicas
134 artigos
Último publicado: 2026 Mar
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: A77
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧬
Pele e cabelo
5 sintomas
🫃
Digestivo
4 sintomas
🩸
Sangue
4 sintomas
🫁
Pulmão
1 sintomas
🫘
Rins
1 sintomas
👁️
Olhos
1 sintomas

+ 9 sintomas em outras categorias

Características mais comuns

Náusea
Descolamento da pele
Diarreia
Erupção cutânea
Cefaleia
Artralgia
26sintomas
Sem dados (26)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 26 características clínicas mais associadas, ordenadas por frequência.

NáuseaNausea
Descolamento da peleSkin detachment
DiarreiaDiarrhea
Erupção cutâneaSkin rash
CefaleiaHeadache

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico134PubMed
Últimos 10 anos75publicações
Pico201912 papers
Linha do tempo
2026Hoje · 2026🧪 2009Primeiro ensaio clínico📈 2019Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 31
·Pré-clínico3
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 4 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Febre macular por rickettsiose

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

0 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
77 papers (10 anos)
#1

Rickettsia parkeri genetic diversity from three different hard tick species (family: Ixodidae).

Parasites & vectors2026 Feb 26

Rickettsia parkeri sensu stricto, a causative agent of spotted fever rickettsiosis, is spread via the bite of infected ticks within the Amblyomma maculatum complex group. In the United States of America (USA), Am. maculatum Koch, 1844 is the primary vector for R. parkeri; however, Amblyomma americanum (Linnaeus, 1758) and Dermacentor variabilis (Say, 1821) have demonstrated potential to transmit R. parkeri under laboratory conditions. In this study, we investigate the genetic differences between R. parkeri detected in Am. maculatum, the primary enzootic vector, and potential secondary vectors - Am. americanum and De. variabilis. Using Nanopore long-read amplicon sequencing, we compared four R. parkeri genes amplified from naturally infected Am. maculatum, Am. americanum, and De. variabilis collected in the USA. Three R. parkeri genes associated with potential virulence factors were sequenced: outer membrane protein A (OmpA/sca0), outer membrane protein B (OmpB/sca5), and surface cell antigen 4 (gene D/sca4). One species-level gene target was used for species confirmation: 16S ribosomal RNA gene (16S). Differences in cellular-entry and pathogen chromosomal genes (OmpA, OmpB, and 16S) were detected within the different tick species. No differences were noted in the cell-to-cell mediated transfer gene (gene D) between tick species. This preliminary study suggests that infection in Am. americanum may lead to changes in R. parkeri genes responsible for pathogen-host cell attachment and replication processes, but once established in a host cell, R. parkeri transfer between cells is unlikely to be impacted.

#2

High prevalence of the Mediterranean spotted fever agent Rickettsia aeschlimannii in Hyalomma marginatum ticks from Pianosa island, Italy.

Parasites & vectors2026 Feb 03

Tick-borne rickettsioses, caused by bacteria of the spotted fever group (SFG) Rickettsia, are emerging infectious diseases whose emergence and spread are often affected by climate and land-use changes. Here, we report the results of monitoring Hyalomma spp. ticks in the protected area of Pianosa island (Tuscany (Italy) and subsequently investigating their bacterial community through metabarcoding sequencing. In this study, based on analyses of 575 tick specimens distributed in 120 pools, we recorded a high prevalence of Rickettsia aeschlimannii (58% and 75% gltA- and 17 kDa-Ag protein-positive pools, respectively), an agent of the SFG group in H. marginatum. These findings support the need for warnings on the risk of transmission of spotted fever rickettsiosis to both residents and visitors and underline the need for enhanced surveillance, public awareness and preventive measures.

#3

Completion of Paired Serological Testing Algorithms for Spotted Fever Rickettsiosis and Ehrlichiosis, North Carolina: 2017-2020.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America2026 Mar 17

Ehrlichia and Rickettsia are tickborne pathogens capable of causing severe disease. Paired serological testing, involving both acute and convalescent samples, remains the primary method of diagnostic confirmation and source of surveillance data. Yet, few patients complete recommended testing algorithms. We examined the demographic, clinical, and geographic factors associated with obtainment of convalescent samples for patients with suspected ehrlichiosis and spotted fever rickettsiosis using results from a large academic center in North Carolina between 2017 and 2020. More than 4400 patients underwent serological testing of an acute sample for Rickettsia (N = 4224) and Ehrlichia (N = 2339); however, only 15.0% (662/4415) had testing performed on a convalescent sample. Over the study period, the proportion of convalescent testing completed increased from 4% to 23% for Ehrlichia, 7% to 11% for Rickettsia, and 12% to 28% for both. A reactive test on the acute sample, undergoing testing for both pathogens, and proximity to a health facility were significantly associated with obtainment and testing of a convalescent sample. The presence of a reactive acute titer for Ehrlichia and Rickettsia had 8.3 (95% confidence interval, 6.3-10.9) and 8.2 (95% confidence interval, 6.5-10.3) times the probability of obtainment of a convalescent sample compared to nonreactive results, respectively. Our findings suggest that clinicians' knowledge of tickborne disease testing practices, in addition to patient distance to health facilities, contribute to poor performance of testing completion. Moreover, these results highlight the need for more investment in public health surveillance and, ultimately, assays that are not dependent on convalescent testing.

#4

Seroprevalence of spotted fever rickettsiosis and ehrlichiosis among food processing workers and their families in Latino communities in North Carolina.

PLOS global public health2025

Workers in food processing industries are subject to many occupational health risks and disparities, but little is known about their risk of tickborne diseases. We examined a cohort of Latino individuals working in the meat packing, produce processing, and farming industries and their family members in central North Carolina, where incidence of tickborne infections is high. Blood samples were tested for IgG antibodies against Spotted Fever Group Rickettsiosis (SFGR) and Ehrlichia chaffeensis. Covariates of interest included age, sex, primary language, work industry, indoor vs. outdoor work, home characteristics, medical comorbidities, and travel history. Among 201 Latino food processing workers and their family members, the seroprevalence of SFGR and Ehrlichia was 14.9% and 19.9%, respectively. Almost a third of participants were seropositive for at least one infection. SFGR seropositive individuals were significantly older than seronegative individuals (median 45 [interquartile range 35-55] vs. 33 [14-45] years, p < 0.001), while Ehrlichia seropositivity appeared to have a bimodal distribution by age, with peaks in children under age 10 and adults in their forties and fifties. Farm workers had higher seroprevalence of SFGR (25.0%) than other workers (13.5%), although this did not reach statistical significance (p = 0.13). Having a seropositive household member for either infection was a risk factor for seropositivity for the same infection, adjusted for age and household clustering (adjusted OR [aOR] 8.26, 95% CI [confidence interval] 3.27-20.90 for SFGR; aOR 11.24, 95% CI 4.24-29.80 for Ehrlichia). Seroprevalence for SFGR and Ehrlichia was similar between index workers and household members when adjusted for age. Our findings indicate that Latino food processing communities in North Carolina have high exposure to tickborne disease, and older age and having seropositive household members are key risk factors.

#5

Spatial and clinical epidemiology of spotted fever rickettsioses and ehrlichiosis, North Carolina, 2010-2019.

PLoS neglected tropical diseases2025 Aug

North Carolina (NC) ranks among the top five states for spotted fever rickettsiosis (SFR) cases and second for ehrlichiosis in the U.S. Identifying geographic clusters of cases is important to elucidate disease risk and inform public health response, including resource allocation. This study examined geographic patterns of tick-borne disease incidence in NC over a 10-year period and modeled predictors of disease severity. We analyzed 6,748 SFR and 1,216 ehrlichiosis cases reported to the NC Electronic Disease Surveillance System between January 2010 and December 2019. Average annual incidence was evaluated in two-year periods using global spatial autocorrelation (Moran's I) and Local Indicator of Spatial Association. We found that ehrlichiosis clusters were detected in north and central NC as well as the coastal Tidewater region, with consistently high incidence in these areas. SFR clustering occurred in similar areas, with high and increasing incidence statewide. Severe cases of ehrlichiosis followed a similar pattern, while severe SFR clusters were distributed more broadly across the state. Additionally, Black/African-American individuals made up a greater proportion of both severe ehrlichiosis and SFR cases relative to non-severe cases. Regression models showed that known tick exposures were associated with lower odds of severe SFR. For SFR, treatment delays of 1-7 days were linked to severity, but delays >7 days were not. In contrast, delays >7 days for ehrlichiosis were associated with lower odds of severe disease. Associations found here between severity and treatment delay may reflect care-seeking behaviors, testing practices, and background seroprevalence. Geographic differences in disease incidence and severity warrant further investigation and future surveillance. Public health interventions should focus on the north-central and Tidewater regions, focusing on exposure risks awareness for outdoor activities and checking for ticks, which could impact treatment timing and ultimately reduce severity.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC47 artigos no totalmostrando 75

2026

Rickettsia parkeri genetic diversity from three different hard tick species (family: Ixodidae).

Parasites &amp; vectors
2026

High prevalence of the Mediterranean spotted fever agent Rickettsia aeschlimannii in Hyalomma marginatum ticks from Pianosa island, Italy.

Parasites &amp; vectors
2025

Anti-Rickettsial Activity of Chitosan, Selenium, and Silver Nanoparticles: Efficacy in Vero Cells.

Pathogens (Basel, Switzerland)
2025

Seroprevalence of spotted fever rickettsiosis and ehrlichiosis among food processing workers and their families in Latino communities in North Carolina.

PLOS global public health
2025

Spatial and clinical epidemiology of spotted fever rickettsioses and ehrlichiosis, North Carolina, 2010-2019.

PLoS neglected tropical diseases
2025

Detection of Rickettsia-Infected Argas (Persicargas) giganteus on Osprey (Pandion haliaetus) from the Northeastern USA.

Journal of wildlife diseases
2025

Seroprevalence of spotted fever group rickettsiosis in Kashmir: A community-based study using indirect immunofluorescence assay.

Indian journal of medical microbiology
2025

Enhanced surveillance for tick-borne rickettsiosis and ehrlichiosis in North Carolina: Protocol and preliminary results.

PloS one
2025

Characterization of Transstadial Transmission of Rickettsia Amblyommatis in Haemaphysalis Longicornis Using Optimized Artificial Membrane Feeding System.

The American journal of tropical medicine and hygiene
2025

Rickettsia Felis Case Cluster in a Military Family.

Military medicine
2026

Completion of Paired Serological Testing Algorithms for Spotted Fever Rickettsiosis and Ehrlichiosis, North Carolina: 2017-2020.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2025

Development of a Recombinase-Mediated Cassette Exchange System for Gene Knockout and Expression of Non-Native Gene Sequences in Rickettsia.

Vaccines
2025

Detection of Amblyomma maculatum and Rickettsia parkeri in prairies of Central Missouri.

Veterinary parasitology, regional studies and reports
2024

Similarities between Ixodes ricinus and Ixodes inopinatus genomes and horizontal gene transfer from their endosymbionts.

Current research in parasitology &amp; vector-borne diseases
2024

Limited evidence of infection with other tick-borne pathogens in patients tested for Lyme neuroborreliosis in the Netherlands.

Ticks and tick-borne diseases
2024

The natural history of Amblyomma maculatum sensu lato, a vector of Rickettsia parkeri rickettsiosis, in southern Arizona.

Scientific reports
2024

Spatial and temporal variation of five different pathogens and symbionts in Ixodes ricinus nymphs in the Netherlands.

Current research in parasitology &amp; vector-borne diseases
2024

Rickettsia parkeri Rickettsiosis in Kidney Transplant Recipient, North Carolina, USA, 2023.

Emerging infectious diseases
2024

Identification of Bacteria and Viruses Associated with Patients with Acute Febrile Illness in Khon Kaen Province, Thailand.

Viruses
2024

Benidipine impairs innate immunity converting sublethal to lethal infections in a murine model of spotted fever rickettsiosis.

PLoS neglected tropical diseases
2024

Science abhors a surveillance vacuum: Detection of ticks and tick-borne pathogens in southern New Mexico through passive surveillance.

PloS one
2023

Susceptibility of Amblyomma sculptum, Vector of Rickettsia rickettsii, Ticks from a National Park and an Experimental Farm to Different Synthetic Acaricides.

Pathogens (Basel, Switzerland)
2023

Spotted fever rickettsioses. Study of cases reported in a secondary care pediatric hospital of northeastern Mexico, 2012-2022.

Gaceta medica de Mexico
2023

[Spotted fever rickettsioses. Study of cases reported in a secondary care pediatric hospital of northeastern Mexico, 2012-2022].

Gaceta medica de Mexico
2023

Tick-Borne Pathogens Associated with Medically Important Ticks in Alabama: A Four-Year Survey.

Vector borne and zoonotic diseases (Larchmont, N.Y.)
2022

Evaluating the Clinical and Immune Responses to Spotted Fever Rickettsioses in the Guinea Pig-Tick-Rickettsia System.

Current protocols
2022

Detection of Rickettsia montanensis in Dermacentor variabilis in Northern Wisconsin.

Vector borne and zoonotic diseases (Larchmont, N.Y.)
2022

Quantitative microbial population study reveals geographical differences in bacterial symbionts of Ixodes ricinus.

Microbiome
2022

Mapping potential risks for the transmission of spotted fever rickettsiosis: The case study from the Rio de Janeiro state, Brazil.

PloS one
2022

Multiplex TaqMan® Quantitative PCR Assays for Host-Tick-Pathogen Studies Using the Guinea Pig-Tick-Rickettsia System.

Pathogens (Basel, Switzerland)
2022

Incidence Rate of Somatic Dysfunction in Previously Undiagnosed Spotted Fever Rickettsiosis: A Case Report.

Cureus
2022

Diagnostic Value of IgA Antibody Measurement in Tick-Borne Spotted Fever (Astrakhan Rickettsial Fever).

Microbiology spectrum
2022

Collaborating With Community Scientists Across Arkansas to Update Tick Distributions and Pathogen Prevalence of Spotted Fever Group Rickettsia and Ehrlichia.

Journal of medical entomology
2021

Patient characteristics, treatment patterns, and outcomes of Rickettsial diseases among a commercially insured population in the United States, 2005-2017.

Scientific reports
2021

Assessing scrub typhus and rickettsioses transmission risks in the Chiang Rai province of northern Thailand.

Travel medicine and infectious disease
2021

Beyond the IFA: Revisiting the ELISA as a More Sensitive, Objective, and Quantitative Evaluation of Spotted Fever Group Rickettsia Exposure.

Pathogens (Basel, Switzerland)
2021

MicroRNA-424 regulates the expression of CX3CL1 (fractalkine) in human microvascular endothelial cells during Rickettsia rickettsii infection.

Biochemistry and biophysics reports
2020

Rickettsia parkeri (Rickettsiales: Rickettsiaceae) detected in Amblyomma maculatum ticks collected on dogs in Tabasco, Mexico.

Experimental &amp; applied acarology
2020

Acute infectious purpura fulminans: a case series from India.

Tropical doctor
2020

Optimization and Evaluation of a Multiplex Quantitative PCR Assay for Detection of Nucleic Acids in Human Blood Samples from Patients with Spotted Fever Rickettsiosis, Typhus Rickettsiosis, Scrub Typhus, Monocytic Ehrlichiosis, and Granulocytic Anaplasmosis.

Journal of clinical microbiology
2020

Emerging tick-borne pathogens of public health importance: a mini-review.

Journal of medical microbiology
2020

Spotted fever rickettsiosis presenting with bilateral anterior uveitis and retinitis: A case report.

Journal of family medicine and primary care
2020

Rickettsia parkeri (Rickettsiales: Rickettsiaceae) in the Sky Islands of West Texas.

Journal of medical entomology
2020

Evaluation of Disease Causality of Rare Ixodes ricinus-Borne Infections in Europe.

Pathogens (Basel, Switzerland)
2020

Surveillance for Amblyomma maculatum (Acari: Ixodidae) and Rickettsia parkeri (Rickettsiales: Rickettsiaceae) in the State of Delaware, and Their Public Health Implications.

Journal of medical entomology
2020

An optimized five-color/seven-parameter flow cytometry panel for immunophenotyping guinea pig peripheral blood lymphocytes.

Journal of immunological methods
2020

Expanding Recognition of Rickettsia parkeri Rickettsiosis in Southern Arizona, 2016-2017.

Vector borne and zoonotic diseases (Larchmont, N.Y.)
2019

A human case of spotted fever caused by Rickettsia parkeri strain Atlantic rainforest and its association to the tick Amblyomma ovale.

Parasites &amp; vectors
2020

Meningoencephalitis due to Spotted Fever Rickettsioses, Including Rocky Mountain Spotted Fever.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2019

Phenology of Amblyomma sculptum in a degraded area of Atlantic rainforest in north-eastern Brazil.

Ticks and tick-borne diseases
2020

Antibody Titers Reactive With Rickettsia rickettsii in Blood Donors and Implications for Surveillance of Spotted Fever Rickettsiosis in the United States.

The Journal of infectious diseases
2019

A biosafety level-2 dose-dependent lethal mouse model of spotted fever rickettsiosis: Rickettsia parkeri Atlantic Rainforest strain.

PLoS neglected tropical diseases
2019

Molecular evidence of Borrelia burgdorferi sensu stricto and Rickettsia massiliae in ticks collected from a domestic-wild carnivore interface in Chihuahua, Mexico.

Ticks and tick-borne diseases
2019

HLA-B27 spondyloarthritis and spotted fever rickettsiosis: case-based review.

Rheumatology international
2019

Lyme borreliosis and other tick-borne diseases. Guidelines from the French Scientific Societies (I): prevention, epidemiology, diagnosis.

Medecine et maladies infectieuses
2019

Spotted fever rickettsiosis in South Africa: Evaluation of laboratory diagnostic capacity and inter-laboratory comparison of serological testing.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
2019

National Surveillance Data Show Increase in Spotted Fever Rickettsiosis: United States, 2016-2017.

American journal of public health
2019

Amblyomma maculatum-associated rickettsiae in vector tissues and vertebrate hosts during tick feeding.

Experimental &amp; applied acarology
2019

Severe leptospirosis in a patient with positive serological test for spotted fever rickettsiosis.

BMJ case reports
2018

Attempt to uncover reservoirs of human spotted fever rickettsiosis on the Fleurieu Peninsula, South Australia.

Journal of vector borne diseases
2019

Vector Tick Transmission Model of Spotted Fever Rickettsiosis.

The American journal of pathology
2018

Spotted Fever Rickettsiosis in a Wildlife Researcher in Sabah, Malaysia: A Case Study.

Tropical medicine and infectious disease
2019

Mediterranean spotted fever rickettsiosis in Italy, 2001-2015: Spatio-temporal distribution based on hospitalization records.

Ticks and tick-borne diseases
2018

Fatal spotted fever rickettsiosis in Argentina.

IDCases
2017

Fibroblast growth factor receptor-1 mediates internalization of pathogenic spotted fever rickettsiae into host endothelium.

PloS one
2017

Seroepidemiology of Spotted Fever Rickettsiosis in Uttar Pradesh: A Prospective Study.

Journal of clinical and diagnostic research : JCDR
2017

Retrospective Case Reports of Two Central North Carolina Residents: Frequency of Tick Bites and Associated Illnesses, 2001-2014.

North Carolina medical journal
2016

Comparative growth of spotted fever group Rickettsia spp. strains in Vero cells.

Memorias do Instituto Oswaldo Cruz
2016

Prevalence of Rickettsia species in Dermacentor variabilis ticks from Ontario, Canada.

Ticks and tick-borne diseases
2016

Comparative value of blood and skin samples for diagnosis of spotted fever group rickettsial infection in model animals.

Ticks and tick-borne diseases
2016

A Clinical Review of Tick-Borne Diseases in Arkansas.

The Journal of the Arkansas Medical Society
2015

Evaluation of a new serological test for the detection of anti-Coxiella and anti-Rickettsia antibodies.

Microbes and infection
2015

Rickettsia massiliae and Rickettsia conorii Israeli Spotted Fever Strain Differentially Regulate Endothelial Cell Responses.

PloS one
2015

Spotted fever rickettsiosis in Uttar Pradesh.

The Indian journal of medical research
2015

Incidence of notifiable diseases among American Indians/Alaska Natives - United States, 2007-2011.

MMWR. Morbidity and mortality weekly report

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Febre macular por rickettsiose.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Febre macular por rickettsiose

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Rickettsia parkeri genetic diversity from three different hard tick species (family: Ixodidae).
    Parasites &amp; vectors· 2026· PMID 41749360mais citado
  2. High prevalence of the Mediterranean spotted fever agent Rickettsia aeschlimannii in Hyalomma marginatum ticks from Pianosa island, Italy.
    Parasites &amp; vectors· 2026· PMID 41634780mais citado
  3. Completion of Paired Serological Testing Algorithms for Spotted Fever Rickettsiosis and Ehrlichiosis, North Carolina: 2017-2020.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America· 2026· PMID 40176320mais citado
  4. Seroprevalence of spotted fever rickettsiosis and ehrlichiosis among food processing workers and their families in Latino communities in North Carolina.
    PLOS global public health· 2025· PMID 40892872mais citado
  5. Spatial and clinical epidemiology of spotted fever rickettsioses and ehrlichiosis, North Carolina, 2010-2019.
    PLoS neglected tropical diseases· 2025· PMID 40802836mais citado
  6. Secondary Hemophagocytic Lymphohistiocytosis in a Rocky Mountain Spotted Fever Patient.
    Cureus· 2026· PMID 41994746recente
  7. Molecular identification and phylogenetic analysis of spotted fever Rickettsiae in peripheral blood from suspected Rickettsiosis cases in Sri Lanka.
    BMC Infect Dis· 2026· PMID 41882617recente
  8. Anti-Rickettsial Activity of Chitosan, Selenium, and Silver Nanoparticles: Efficacy in Vero Cells.
    Pathogens· 2025· PMID 41011786recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:102022(Orphanet)
  2. MONDO:0001195(MONDO)
  3. GARD:19828(GARD (NIH))
  4. Busca completa no PubMed(PubMed)
  5. Q9274700(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Febre macular por rickettsiose
Compêndio · Raras BR

Febre macular por rickettsiose

ORPHA:102022 · MONDO:0001195
CID-10
A77 · Febre maculosa [rickettsioses transmitidas por carrapatos]
CID-11
MedGen
UMLS
C0038041
Repurposing
22 candidatos
aspirincyclooxygenase inhibitor
chloramphenicolbacterial 50S ribosomal subunit inhibitor
chloramphenicol-palmitateprotein synthesis inhibitor
+17 outros
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades